Sign in

CIK 0001517022 · Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
208756903
Phone
617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Grant or award Director acquired 44,919 shares (grant or award)
  2. 4 Grant or award Director acquired 11,229 shares (grant or award)
  3. 4 Grant or award Director acquired 10,231 shares (grant or award)
  4. 4 Grant or award Director acquired 3,743 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4 Grant or award Director acquired 7,486 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. 4 Shares withheld for taxes SVP, Chief Development Officer gave up 11,928 shares (to pay taxes)
  15. 4 Shares withheld for taxes SVP, Chief Medical Officer gave up 8,659 shares (to pay taxes)
  16. 4 Shares withheld for taxes SVP, General Counsel, Sec. gave up 20,175 shares (to pay taxes)
  17. 4 Shares withheld for taxes SVP, Chief Business Officer gave up 23,385 shares (to pay taxes)
  18. 4 Shares withheld for taxes CEO & President gave up 135,697 shares (to pay taxes)
  19. 4 Insider Changes in Ownership
  20. 8-K Event Material agreement · Acquisition or sale completed · Executive or director change · Shareholder vote results

Page 27 of 45 · 886 filings